Dossier
mainland Chinese biotechnology firms
Coverage of mainland Chinese biotechnology firms in the Nexus archive.
- Funding option: royalties giant opens Hong Kong base as mainland China biotech deals surge
The world's largest biopharmaceutical royalties buyer has established its first Asia-Pacific base in Hong Kong as mainland Chinese biotech firms' out-licensing deals reach record highs. Royalty financing is being used as an alternative capital-raising method amid US investment restrictions.
- Funding option: royalties giant opens Hong Kong base as mainland China biotech deals surge
The world’s largest biopharmaceutical royalties buyer has established its first Asia-Pacific base in Hong Kong as mainland Chinese biotech firms drive record out-licensing deals. Royalty financing is highlighted as an alternative capital-raising method amid US investment restrictions.